tpan.com Quick Links

2004 HIV Drug Guide

2004 HIV Services Directory

Positively Aware

Positively Aware en Español

Editor's Note:

Going Clinical?

 

Earlier this year I had my third colonoscopy in three years. A colonoscopy is a procedure that detects and prevents colon cancer. In all three procedures my physician had removed pre-cancerous polyps. If these polyps had gone undetected they could have developed into cancerous tumors. Following this last colonoscopy I was asked to join a three-year research study intended to investigate if a certain experimental drug can decrease or prevent the recurrence of polyps.

Today cancer of the colon, like AIDS, is one of the worst killers in the United States. This is mainly because of stigmas attached to disease and discomfort in dealing with treatment. I decided to join this study because if this experimental drug is successful it may reduce the risk of colon cancer in individuals like myself.

People take part in clinical trials for a number of reasons. You may want to help in the development of medical therapies and vaccines that may help treat or even cure life-threatening and chronic diseases. You may suffer from a disease for which good treatments do not presently exist, and decide to join a study hoping to obtain improved medical care. Or you may not have health insurance, and clinical trials provide study related medical care.

A clinical trial is a study that is carefully monitored by a physician or a research professional. They are usually conducted in four phases (I, II, III, IV). Each phase requires a larger number of participants. They require people like you and me to volunteer to receive investigational treatments. All clinical trials are reviewed by the U.S. government’s Food and Drug Administration (FDA) and by Institutional Review Boards (IRBs). The IRB ensures that your rights and privacy are protected, that you aren’t exposed to any unnecessary risks, and that you have signed a consent form prior to entering a trial.

Once accepted into a study group you will receive a physical examination. Your physician or research professional will review your medical history. A detailed description of your specific clinical trial, what’s expected, duration and expected outcomes will be outlined. You will then be placed into a study group.

In order to make your experience in a clinical trial a safe one, it is important that medication is taken as prescribed, that you keep all scheduled appointments, and that you keep a log of how you are feeling between appointments. The information you provide in regards to any symptoms or side effects you may experience is valuable.

There are a number of valuable resources available if you are considering entering an AIDS clinical trial. The AIDS Clinical Trial Information Service is confidential, maintains a trained staff and provides a list of new drugs being tested, where studies are being conducted and who is running the studies (available Monday-Friday 9 am to 7 pm EST, 1-800-TRIALS-A [874-2572]). In addition, the American Foundation for AIDS Research (amfAR) provides information on both basic-biomedical and clinical AIDS research (1-212-806-1600, txdir@amfar.org and www.amfar.org).

For whatever reasons that you might choose for taking part in a clinical trial, it’s ultimately important that you make an informed choice and have all of your questions about the trial and study drug answered. And remember you have the right to leave a study at any time and for any reason.

 

Charles E. Clifton


Send comments and reactions to posaware@aol.com

| Positively Aware | 2004 HIV Drug Guide | Positively Aware en español |

|Chicago Area HIV Services Directory | Publications Home |

| Publications | Client Services | MOCHA | Events | Helping TPAN |

| Contacts and Staff | About TPAN | Ask TPAN | Links | TPAN Home |